Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL442699 | 0.76 | ALDH1A1 (0.32) | NPSR1 | |
| Hydrochloric Acid SCHEMBL14777373 | 0.74 | — | — | |
| SCHEMBL819057 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL1697483 | 0.71 | MAPT (0.34) | NPSR1 | |
| SCHEMBL18287206 | 0.71 | — | — | |
| SCHEMBL29603795 | 0.71 | ALDH1A1 (0.34) | HRH3NPSR1 | |
| Bromide SCHEMBL4539689 | 0.69 | ALDH1A1 (0.33) | HRH3NPSR1 | |
| SCHEMBL21722392 | 0.69 | ALDH1A1 (0.33) | HRH3NPSR1 | |
| SCHEMBL29603410 | 0.69 | ALDH1A1 (0.33) | HRH3NPSR1 | |
| SCHEMBL1178759 | 0.69 | ALDH1A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9024034-B2 | Metathesis catalysts and processes for use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-20110112302-A1 | Metathesis Catalysts and Processes for Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-05-12 | — | — | US | disclosed |
| WO-2011056874-A2 | METATHESIS CATALYSTS AND PROCESSES FOR USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110112302-A1 | Metathesis Catalysts and Processes for Use Thereof | FASN, LIPC, MGLL | HRH3 2111/4885NPSR1 3332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.